đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This surveillance's objectives are: 1. Unknown adverse reactions 2. Incide...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-06
Trial ID
NCT02269995
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of Irinotec...
Status
Terminated
Location
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Start Date
2010-02
Trial ID
NCT01060423
Treatments Being Tested
The primary purpose of the study is to evaluate the distribution of radiopa...
Status
Completed
Location
Evgenidion Hospital
Start Date
2018-05-02
Trial ID
NCT03474354
Treatments Being Tested
The objective of this study is to assess the safety and efficacy of DC Bead...
Status
Completed
Location
Medizinische Universitat Innsbruck
Start Date
2005-11
Trial ID
NCT00261378
Treatments Being Tested
Safety and efficacy of doxorubicin-eluting-bead embolization in patients wi...
Status
Unknown
Location
Seoul National University
Start Date
2015-09
Trial ID
NCT02525380
Treatments Being Tested
The purpose of this study is to assess feasibility of chemoembolization wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01631539
Treatments Being Tested
The most frequently used products in CHE are doxorubicin (36%), cisplatin (...
Status
Completed
Location
CHU Amiens
Start Date
2015-01
Trial ID
NCT02185768
Treatments Being Tested
The Aim is to evaluate safety and efficacy of TACE with doxorubicin-loaded ...
Status
Unknown
Location
SLK Klinikum
Start Date
2010-06
Trial ID
NCT01409733
Treatments Being Tested
Purpose: The purpose of this study is to determine the feasibility and saf...
Status
Completed
Location
The Johns Hopkins Hospital
Start Date
2014-02
Trial ID
NCT02015754
Treatments Being Tested
This is a study protocol for the use of a novel radiopaque embolic agent in...
Status
Unknown
Location
Southampton General Hospital, University Hospital Southampton
Start Date
2017-06-02
Trial ID
NCT03109925
Treatments Being Tested